Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

SHE:002424 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 11, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	5,829	5,255	11,236	11,404	10,622	11,050
Market Cap Growth	-43.46%	-53.23%	-1.47%	7.37%	-3.87%	-10.10%
Enterprise Value	7,062	6,933	12,721	12,731	12,179	12,803
Last Close Price	4.27	3.85	8.11	8.16	7.60	7.83
PE Ratio	956.05	156.31	-	82.36	89.65	72.52
Forward PE	-	17.71	17.71	17.71	17.71	17.71
PS Ratio	1.79	1.37	2.64	3.22	3.41	3.58
PB Ratio	1.81	1.64	3.42	2.85	2.74	2.82
P/TBV Ratio	1.96	1.78	3.69	3.03	2.92	2.96
P/FCF Ratio	17.80	-	519.03	26.30	-	24.32
P/OCF Ratio	15.91	582.59	89.34	22.71	32.69	20.30
EV/Sales Ratio	2.17	1.81	2.98	3.60	3.92	4.15
EV/EBITDA Ratio	87.86	55.88	-	38.96	38.29	43.69
EV/EBIT Ratio	-	353.32	-	56.98	54.65	65.14
EV/FCF Ratio	21.56	-	587.59	29.35	-	28.18
Debt / Equity Ratio	0.50	0.56	0.51	0.39	0.44	0.58
Debt / EBITDA Ratio	20.14	13.30	-	4.62	5.20	7.74
Debt / FCF Ratio	4.94	-	77.89	3.61	-	4.99
Asset Turnover	0.44	0.53	0.60	0.53	0.46	0.44
Inventory Turnover	1.36	1.46	1.98	1.76	1.58	1.51
Quick Ratio	0.68	0.64	0.73	1.07	1.09	1.29
Current Ratio	1.00	0.96	1.06	1.38	1.45	1.61
Return on Equity (ROE)	0.30%	1.14%	-11.33%	3.46%	2.81%	3.82%
Return on Assets (ROA)	-0.29%	0.17%	-3.52%	2.09%	2.06%	1.75%
Return on Capital (ROIC)	-0.43%	0.25%	-4.78%	2.50%	2.37%	1.93%
Return on Capital Employed (ROCE)	-	0.60%	-	5.40%	5.50%	4.70%
Earnings Yield	0.10%	0.64%	-3.69%	1.21%	1.11%	1.38%
FCF Yield	5.62%	-0.63%	0.19%	3.80%	-0.95%	4.11%
Payout Ratio	1288.07%	241.94%	-	62.50%	84.56%	283.23%
Buyback Yield / Dilution	-20.73%	-21.67%	0.22%	6.50%	-6.92%	2.02%
Total Shareholder Return	-	-21.67%	0.22%	6.50%	-6.92%	2.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.